Molecular Therapy Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.5 | Q1 | 89.0% | 1.790 | Q1 | 94.2% |
| 2024 | 5.3 | Q1 | 81.6% | 1.716 | Q1 | 93.9% |
| 2023 | — | — | — | 0.0% | ||
| 2022 | — | — | — | 0.0% | ||
| 2021 | — | — | — | 0.2% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2950-3299
country
UScoverage
2024-2026